Table 1.
Characteristics of CBCS participants with genotypmg data
Characteristic | Cases |
Controls |
||||||
---|---|---|---|---|---|---|---|---|
African American |
Caucasian |
African American |
Caucasian |
|||||
N | % | N | % | N | % | N | % | |
|
|
|
|
|
|
|
|
|
N | 742 | 100 | 1204 | 100 | 658 | 100 | 1089 | 100 |
Median age in years (range) | 51 (23–74) | 50 (24–74) | 50 (26–74) | 51 (21–74) | ||||
Proportion of European ancestry Mean (range) | 0.222 (0.054–0.962) | 0.936 (0.110–1) | 0.226 (0.045–1) | 0.934 (0.083–1) | ||||
Age (years) | ||||||||
<50 | 355 | 47.8 | 592 | 49.2 | 314 | 47.7 | 491 | 45.1 |
>=50 | 387 | 52.2 | 612 | 50.8 | 344 | 52.3 | 598 | 54.9 |
Menopausal status | ||||||||
Premenopausal | 324 | 43.7 | 540 | 44.9 | 290 | 44.1 | 456 | 41.9 |
Postmenopausal | 418 | 56.3 | 664 | 55.2 | 368 | 55.9 | 633 | 58.1 |
Stage | ||||||||
CISa | 88 | 11.9 | 349 | 29.0 | ||||
1 | 216 | 29.1 | 393 | 32.6 | ||||
2 | 299 | 40.3 | 328 | 27.2 | ||||
3 | 76 | 10.2 | 68 | 5.7 | ||||
4 | 27 | 3.6 | 15 | 1.3 | ||||
Missingb | 36 | 4.9 | 51 | 4.2 | ||||
Tumor Marker Status | ||||||||
ER+ | 322 | 43.4 | 672 | 55.8 | ||||
ER− | 341 | 46.0 | 344 | 28.6 | ||||
Missing | 79 | 10.6 | 188 | 15.6 | ||||
ER−/PR−/HER2− | 203 | 27.4 | 145 | 12.0 |
CIS carcinoma in situ
Invasive breast cancer cases